Search
for
Sort by
Research 571–600 of 1000+
- Retrospective Study about the Effectiveness of Korean Medical Treatment on 222 Patients with Alopecia Areata
- Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA)
- Effectiveness of baricitinib in severe alopecia areata in real life: a retrospective study of 87 patients
- Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trial
- Evaluation of the level of serum Interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata
- Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
- The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside
- SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024
- The first 20 years of skin of color dermatology: An era of advancements in skin, hair, and nail disorders
- Efficacy and safety of tofacitinib in patients with alopecia areata
- Successful Remission of Alopecia Areata and Seborrheic Dermatitis in a 21-Year-Old Male via Functional Nutrition and Advanced Diagnostics: A Case Report.
- Molecular crosstalk between lncRNA H19, miR-29a, and JAK2/STAT3 signaling in alopecia areata: a preliminary study
- Healing hair naturally: A case study of alopecia areata treated with individualized homeopathy
- Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023)
- Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity
- SARS-CoV-2 Infection and Alpha-Synucleinopathies: Potential Links and Underlying Mechanisms
- 42004 Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study
- TYK2 Inhibition with Deucravacitinib Improves Clinical Outcomes and Resolves Interferon-Driven Inflammation in Lichen Planopilaris
- Alopecia Areata: An Updated Review for 2023
- The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience
- Wound Healing Impairment in Type 2 Diabetes Model of Leptin-Deficient Mice—A Mechanistic Systematic Review
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial
- Dermoscopy — 4th Conference of the Section of Dermoscopy and Other Skin Imaging Techniques (DiTOS) of the Polish Dermatological Society — Abstracts
- SnapshotDx Quiz: April 2022
- Androgenetic alopecia – Update 2022
- Platycladus orientalis Leaf Extract Promotes Hair Growth via Non-Receptor Tyrosine Kinase ACK1 Activation
- Update From Dermatology Nurses’ Association Convention 2025